Targeting the B-cell receptor (BCR) signaling pathway in Burkitt lymphoma (BL)

被引：0
|
作者：
Cairo, Mitchell S. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA
[2] New York Med Coll, Dept Med, Valhalla, NY 10595 USA
[3] New York Med Coll, Dept Pathol, Microbiol, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Immunol, Valhalla, NY 10595 USA
[5] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 171卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
43
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [41] Dysregulation of MYC Driven By BCR-PI3K-AKT Signaling Pathway in Diffuse Large B-Cell Lymphoma
    Wang, Wei-Ge
    Jiang, Xiang-Nan
    Liu, Ze-Bing
    Zhou, Xiao-Yan
    Li, Xiao-Qiu
    MODERN PATHOLOGY, 2015, 28 : 385A - 385A
  • [42] PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF THE B-CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA
    Gambino, S.
    Quaglia, F. M.
    Galasso, M.
    Cavallini, C.
    Chignola, R.
    Lovato, O.
    Aparo, A.
    Ferrarini, I.
    Giugno, R.
    Krampera, M.
    Visco, C.
    Scupoli, M. T.
    HAEMATOLOGICA, 2024, 109 : 97 - 97
  • [43] Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma
    Rodgers, Thomas D.
    Reagan, Patrick M.
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (02) : 111 - 122
  • [44] Targeting of B-cell receptor signalling in B-cell malignancies
    Jerkeman, M.
    Hallek, M.
    Dreyling, M.
    Thieblemont, C.
    Kimby, E.
    Staudt, L.
    JOURNAL OF INTERNAL MEDICINE, 2017, 282 (05) : 415 - 428
  • [45] Targeting the B cell receptor signaling pathway in chronic lymphocytic leukemia
    Patton, John T.
    Woyach, Jennifer A.
    SEMINARS IN HEMATOLOGY, 2024, 61 (02) : 100 - 108
  • [46] Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
    Bellan, Cristiana
    Stefano, Lazzi
    Giulia, De Falco
    Rogena, Emily A.
    Lorenzo, Leoncini
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 53 - 56
  • [47] Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
    Bellan, Cristiana
    Stefano, Lazzi
    Giulia, De Falco
    Rogena, Emily A.
    Lorenzo, Leoncini
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (04) : 182 - 185
  • [48] DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway
    Chang, Shuaikang
    Li, Bo
    Xie, Yongsheng
    Wang, Yingcong
    Xu, Zhijian
    Jin, Shuhan
    Yu, Dandan
    Wang, Huaping
    Lu, Yumeng
    Zhang, Yong
    Ma, Ruye
    Huang, Cheng
    Lai, Weiming
    Wu, Xiaosong
    Zhu, Weiliang
    Shi, Jumei
    NEOPLASIA, 2022, 24 (01): : 50 - 61
  • [49] A Case of B-cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-cell Lymphoma and Burkitt Lymphoma in a Korean Child
    Ahn, Jeong Yeal
    Seo, Yiel Hea
    Park, Pil Whan
    Kim, Kyung Hee
    Park, Mi Jung
    Jeong, Ji Hoon
    Park, Soon Ho
    Song, Young Hee
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (02) : 162 - 166
  • [50] Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma
    Baryakh, E. A.
    Misyurina, A. E.
    Kovrigina, A. M.
    Obukhova, T. N.
    Gemdzhyan, E. G.
    Vorobyev, V. I.
    Mangasarova, Ya. K.
    Polyakov, Yu. Yu.
    Magomedova, A. U.
    Klyasova, G. A.
    Misyurin, V. A.
    Yatsyk, G. A.
    Shevelev, A. A.
    Kostina, I. E.
    Vorobyev, A. I.
    Kravchenko, S. K.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (08) : 77 - 85
12345